Seroma of the Mammary Gland
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity Hospital Augsburg
About this trial
The study is designed as international, prospective, minimal interventional study in cooperation with EUBREAST e.V. (European Breast Cancer Research Association of Surgical Trialists). Furthermore, it is planned to initiate a registry for postoperative breast seromas.
Eligibility criteria
Qualifiers
Written informed consent
Age ≥ 18 years
all stages of DCIS or primary breast cancer (T1-T4, N0 or N+, M0) including all histopathological subtypes (ER/PR positive, ER positive/PR negative, Her-2/neu positive and triple negative)
Surgical procedure planned including ablatio or subcutaneous mastectomy with implant or expander insertion
Disqualifiers
Age <18 years
Male sex
Breast cancer patients planned for breast conserving therapy
Recurrent breast cancer disease
Trial design
Treatments tested in this trial
- Swap collection
- Seroma punction
- Blood sampling
- Sonographic correlation Seroma
Treatment groups
2,000 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov